Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate
Clinical trial NCT02288312 · COMPLETED
Trial details
- NCT number
- NCT02288312
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2007-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.